Sinovac Biotech annual stock-based compensation
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Sinovac Biotech Stock-Based Compensation Growth & History (SVA)
Sinovac Biotech's stock-based compensation was $0 for fiscal 2025.
View full Sinovac Biotech company overviewSinovac Biotech annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | −$7.7M | — |
| 2021 | 2021-12-31 | $7.7M | −$2.5M | −24.19% |
| 2020 | 2020-12-31 | $10.2M | $7.2M | +239.76% |
| 2019 | 2019-12-31 | $3.0M | −$1.3M | −30.24% |
| 2018 | 2018-12-31 | $4.3M | $3.3M | +339.73% |
| 2017 | 2017-12-31 | $979,000 | −$1.4M | −59.36% |
| 2016 | 2016-12-31 | $2.4M | $1.5M | +153.05% |
| 2015 | 2015-12-31 | $952,000 | $665,000 | +231.71% |
| 2014 | 2014-12-31 | $287,000 | $6,000 | +2.14% |
| 2013 | 2013-12-31 | $281,000 | −$66,000 | −19.02% |
| 2012 | 2012-12-31 | $347,000 | $141,000 | +68.45% |
| 2011 | 2011-12-31 | $206,000 | −$253,901 | −55.21% |
| 2010 | 2010-12-31 | $459,901 | $37,041 | +8.76% |
| 2009 | 2009-12-31 | $422,860 | — | — |
Sinovac Biotech stock-based compensation trends
Over the last five fiscal years, Sinovac Biotech's stock-based compensation decreased from $10.2M to $0, a change of −$10.2M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sinovac Biotech source filings ↗